solid tumors
- مهر- 1397 -25 مهر
Transgene Unveils myvacTM, an Individualized Immunotherapy against Solid Tumors
Transgene Unveils myvacTM, an Individualized Immunotherapy against Solid Tumors STRASBOURG, France–(BUSINESS WIRE)–Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG) a biotechnology company that designs and develops…
-- بیشتر بخوانید -- - دی- 1396 -12 دیدیگر
First-in-class ERK1/2 inhibitor safe, shows early efficacy in patients with advanced solid tumors
The novel ERK1/2 kinase inhibitor ulixertinib displayed an acceptable safety profile and had clinical activity in patients whose tumors had mutations in the MAPK cell-signaling…
-- بیشتر بخوانید -- - مرداد- 1396 -29 مرداددیگر
پیشرفت درمان تومورهای جامد اطفال
St. Jude unveils powerful resource to advance treatment of pediatric solid tumors (MEMPHIS, Tenn. – Aug. 30, 2017) In an effort to improve outcomes for…
-- بیشتر بخوانید --
